HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiayang Kuang Selected Research

Colonic Neoplasms (Colon Cancer)

10/2023Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiayang Kuang Research Topics

Disease

1Colonic Neoplasms (Colon Cancer)
10/2023
1Neoplasms (Cancer)
10/2023

Drug/Important Bio-Agent (IBA)

1regorafenibIBA
10/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023
1JNK Mitogen-Activated Protein KinasesIBA
10/2023